Nycomed snags Bruker contrast injector

February 14, 2001

The increasing speed of MRI and CT systems and their expanding vascular indications have made precision and reproducibility paramount considerations in contrast-enhanced studies. In mid-January, Nycomed Amersham locked in access to this technology,

The increasing speed of MRI and CT systems and their expanding vascular indications have made precision and reproducibility paramount considerations in contrast-enhanced studies. In mid-January, Nycomed Amersham locked in access to this technology, acquiring a sophisticated power injector system from Swiss-based manufacturer Bruker. Called Tomoject, this pump injector provides the constant and reliable flow of contrast media necessary for ultrafast imaging, including contrast-enhanced angiography, tumor diagnostics, organ perfusion, and incremental body imaging. Tomoject is currently marketed in Europe and other international venues. The manufacturing site will remain Zurich.